IGF1 LR3 vs BPC-157 BPC-157 is a synthetic peptide derived from a protective protein found in gastric juice
After reconstitution, research peptides are commonly stored refrigerated to maintain stability .
Pauli, G
IGF-1 LR3s non-selective receptor activation stimulates collagen synthesis and chondrocyte proliferation in cartilage, tendons, and ligaments not just skeletal muscle
Quick Reference: Injection site reactions: 15-25% (mild, resolve in 2-24 hours) Nausea: 5-10% (transient, first week) Dizziness: 3-7% (occasional, brief) Serious events: Zero documented in 100+ animal studies Typical dose: 250-500 mcg/day SubQ
GLOW Blend Synthesized and Lyophilized in Canada by Koi Peptides Domestic Co-Lyophilization at a Canadian Facility Each of the three peptides is built by solid-phase synthesis as a separate run at the Canadian production partner, purified individually, then volumetrically combined at the 50/10/10 mg ratio prior to a single co-lyophilization step